Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.
Karlsson K, Strömberg M, Liliemark J, Delannoy A, Johnson SA, Porwit A, Kimby E, Lärfars G, Cristiansen I, Nilsson G, Celsing F, Sundström G, Luthman M, Tidefelt U, Wallvik J, Juliusson G. Karlsson K, et al. Among authors: juliusson g. Br J Haematol. 2002 Mar;116(3):538-48. doi: 10.1046/j.0007-1048.2001.03296.x. Br J Haematol. 2002. PMID: 11849209 Free article. Clinical Trial.
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study.
Juliusson G, Höglund M, Karlsson K, Löfgren C, Möllgård L, Paul C, Tidefelt U, Björkholm M; Leukemia Group of Middle Sweden. Juliusson G, et al. Br J Haematol. 2003 Dec;123(5):810-8. doi: 10.1046/j.1365-2141.2003.04702.x. Br J Haematol. 2003. PMID: 14632771 Free article. Clinical Trial.
Low-dose cladribine for symptomatic hairy cell leukaemia.
Juliusson G, Lenkei R, Tjønnfjord G, Heldal D, Liliemark J. Juliusson G, et al. Br J Haematol. 1995 Mar;89(3):637-9. doi: 10.1111/j.1365-2141.1995.tb08377.x. Br J Haematol. 1995. PMID: 7734367 Clinical Trial.
Application of population pharmacokinetics to cladribine.
Lindemalm S, Savic RM, Karlsson MO, Juliusson G, Liliemark J, Albertioni F. Lindemalm S, et al. Among authors: juliusson g. BMC Pharmacol. 2005 Mar 9;5:4. doi: 10.1186/1471-2210-5-4. BMC Pharmacol. 2005. PMID: 15757511 Free PMC article.
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP, Karlsson K, Strömberg M, Jønsson V, Gill D, Hammerström J, Hertzberg M, McLennan R, Uggla B, Norman J, Wallvik J, Sundström G, Johansson H, Brandberg Y, Liliemark J, Juliusson G; Scandinavian and Australasian Leukaemia Lymphoma Groups (Allg). Mulligan SP, et al. Among authors: juliusson g. Leuk Lymphoma. 2014 Dec;55(12):2769-77. doi: 10.3109/10428194.2014.893306. Epub 2014 Apr 16. Leuk Lymphoma. 2014. PMID: 24524339 Clinical Trial.
286 results